bankrx
- Cassava Sciences (NASDAQ:SAVA) announced on Monday the retirement of James W. Kupiec, Chief Medical Officer, effective May 9, 2025.
- The company also appointed Jack Moore, as Senior Vice President, Clinical Development, reporting to Rick Barry, Chief Executive Officer.
More on Cassava Sciences
- Cassava Sciences: Downside From Alzheimer’s Results Still Possible Despite New Developments
- Cassava: Low-Cost Pivot Into TSC Epilepsy Is Unlikely To Create Long-Term Value
- 4 stocks to watch on Tuesday: GME, TSLA, SAVA and CCI
- Cassava to phase out Alzheimer’s program by Q2
- Seeking Alpha’s Quant Rating on Cassava Sciences